Major cardiovascular events associated with anti-IL 12/23 agents: A tale of two meta-analyses - 18/04/13
Doi : 10.1016/j.jaad.2013.01.011
Erica D. Dommasch, MD a, ⁎ 
, Andrea B. Troxel, ScD b, c, Joel M. Gelfand, MD, MSCE b, c, d
, Andrea B. Troxel, ScD b, c, Joel M. Gelfand, MD, MSCE b, c, d a Department of Dermatology, Boston University, Boston, Massachusetts
b Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania
c Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania
d Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania
Reprint requests: Erica D. Dommasch, MD, 609 Albany St, J-200, Boston, MA 02118.Abbreviations used : CI, FDA, IL, MACE, OR, RCT
Le texte complet de cet article est disponible en PDF.
Plan
| Supported by National Institute of Health/National Heart, Lung, and Blood Institute grant R01-HL089744 (Drs Gelfand and Troxel). |
|
| Drs Dommasch and Troxel have no relevant financial relationships to declare. Dr Gelfand has received grants from Amgen, Pfizer, Novartis, Genentech, and Abbott, and is a consultant for Amgen, Abbott, Pfizer, Novartis, Celgene, Merck, and Janssen. |
© 2013
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 68 - N° 5
P. 863-865 - mai 2013 Retour au numéro
Article précédent
- A model in dermatology for long-distance mentoring
- Caroline C. Kim, Ellen J. Kim, Clara Curiel-Lewandrowski, Victor Marks, Mary Maloney, Ilona J. Frieden
- Counterpoint: Should dermatology residents accept educational support sponsored or funded by pharmaceutical companies?
- Lionel Bercovitch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?